BioForce’s new emerging tech division to commercialize R&D

August 22, 2007 — BioForce Nanosciences Inc., a wholly owned subsidiary of BioForce Nanosciences Holdings, has established a new division, Emerging Technologies. Dr. Saju Nettikadan has been appointed director and will oversee commercializing in-house R&D and collaborations with BioForce instrument customers. Dr. Nettikadan has been director of BioForce’s ViriChip and Chip-on-a-Tip projects

BioForce Nanosciences develops and commercializes nanotech tools and solutions for the life science, including its flagship product, the Nano eNabler molecular printer. Anticipated scientific applications developed within the BioForce laboratory or in users’ facilities have the potential for significant future revenue.

POST A COMMENT

Easily post a comment below using your Linkedin, Twitter, Google or Facebook account. Comments won't automatically be posted to your social media accounts unless you select to share.